LineaRx, EvviVax Publish Additional Positive Animal Proof-of-Concept Data
July 25th, 2022
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Press Release
Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production
July 22nd, 2022
LinearDNA: Alternative to Plasmid DNA for Therapeutic Applications
June 29th, 2022
U.S. Gov’t Guidance Permits DNA Traceability, Isotopic Testing as Evidence
June 21st, 2022
Positive Preclinical Data for LinearDNA™ as Novel Cancer Vaccine Strategy
June 7th, 2022
Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
May 12th, 2022
APDN Schedules FY’22 Q2 Results Conference Call & Webcast
May 9th, 2022
APDN Awarded NYC-based ‘Return-to-Office’ Health Services Contract
April 6th, 2022
Applied DNA to Participate in 2022 Maxim Virtual Growth Conference
March 23rd, 2022